About Our Center
Our entire team is deeply involved in cutting-edge research aimed at furthering our understanding of the transcatheter treatment of structural heart disease. We are currently enrolling patients in several clinical trials of aortic valve replacement and mitral valve replacement/repair.
Treating Structural Heart Disease
Johns Hopkins cardiologist Jon Resar discusses the Structural Heart Disease Clinic at Johns Hopkins and answers commonly asked questions about transcatheter aortic valve replacement (TAVR) to treat aortic stenosis. The TAVR procedure, a Johns Hopkins innovation, is a less invasive approach than traditional open heart surgery. The TAVR procedure is offered by Johns Hopkins Medicine in both Baltimore and DC.